肾癌的现代管理

Trends in Urology, Gynaecology & Sexual Health Pub Date : 2008-09-01 DOI:10.1002/TRE.83

T. Swallow, C. Anderson

{"title":"肾癌的现代管理","authors":"T. Swallow, C. Anderson","doi":"10.1002/TRE.83","DOIUrl":null,"url":null,"abstract":"Although the prognosis for patients with metastatic kidney cancer is poor, those presenting with localised disease are potentially curable with nephrectomy alone. The authors explain how newer, targeted therapeutic agents show promise of extending survival, and outline recent advances in surgical options and the development of more precise prognostic indicators of disease progression and survival. Copyright © 2008 Wiley Interface Ltd","PeriodicalId":178319,"journal":{"name":"Trends in Urology, Gynaecology & Sexual Health","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2008-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Modern management of renal cancer\",\"authors\":\"T. Swallow, C. Anderson\",\"doi\":\"10.1002/TRE.83\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although the prognosis for patients with metastatic kidney cancer is poor, those presenting with localised disease are potentially curable with nephrectomy alone. The authors explain how newer, targeted therapeutic agents show promise of extending survival, and outline recent advances in surgical options and the development of more precise prognostic indicators of disease progression and survival. Copyright © 2008 Wiley Interface Ltd\",\"PeriodicalId\":178319,\"journal\":{\"name\":\"Trends in Urology, Gynaecology & Sexual Health\",\"volume\":\"51 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Urology, Gynaecology & Sexual Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/TRE.83\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Urology, Gynaecology & Sexual Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/TRE.83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Modern management of renal cancer

Although the prognosis for patients with metastatic kidney cancer is poor, those presenting with localised disease are potentially curable with nephrectomy alone. The authors explain how newer, targeted therapeutic agents show promise of extending survival, and outline recent advances in surgical options and the development of more precise prognostic indicators of disease progression and survival. Copyright © 2008 Wiley Interface Ltd

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Trends in Urology, Gynaecology & Sexual Health

自引率

0.00%

发文量